Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own version of Novo Nordisk’s Wegovy oral weight-loss drug.



Source link

administrator

Leave a Reply

Your email address will not be published. Required fields are marked *

16 Free MMOs Worth Settling Down With

7 Common Financial Fees You Should Never Pay

Related Posts

Limping to All-Star break, Timberwolves hope Hawks can cure ills

By  

Is it Crow-maggedon? Why Crows Are Flocking to Bay Area Cities Each Winter

By  

Crispy Chicken Schnitzel Recipe (Easy Pan Fried Dinner)

By  

Is The Sacred Irminsul Symbol Of The Saxons Linked To Yggdrasil And God Odin?

By